| Docetaxel |
20100475 |
DOCETAXEL HOSPIRA, Concentrate for solution for infusion, 10 mg/ml - 2 ml, mg, Pack: 1 |
Hospira UK Ltd., Обединено Кралство |
Hospira UK Ltd. QUEENSWAY, Великобритания, Hospira S.p.A, Италия |
18.8 |
3.76 |
22.56 |
6% |
1.13 |
19.93 |
3.99 |
23.92 |
18% |
3.38 |
23.31 |
4.66 |
27.97 |
цената е заличена с решение НСР-6654/09.07.2015 (в сила от 02.08.2015 ) |
НСР-3735/06.06.2014 |
23.06.2014 |
23.06.2014 |
Заличен |
2924 |
| Docetaxel |
№ II-10282/16.07.2010г. |
DOCETAXEL HOSPIRA, Concentrate for solution for infusion, 10 mg/ml - 16 ml, mg, Pack: 1 |
Hospira UK Ltd., Обединено Кралство |
Hospira UK, Ltd Queensway Royal Leamington Spa Warwiskshire CV313RW, Обединеното кралство;Hospira S.p.a Via Fosse Ardeatine 2, Liscate, Италия |
583.44 |
116.69 |
700.13 |
4% |
10 |
593.44 |
118.69 |
712.13 |
16% |
25 |
618.44 |
123.69 |
742.13 |
|
НСР-3182/07.04.2014 |
21.04.2014 |
21.04.2014 |
Неактивен |
1299 |
| Docetaxel |
№ II-10282/16.07.2010г. |
DOCETAXEL HOSPIRA, Concentrate for solution for infusion, 10 mg/ml - 16 ml, mg, Pack: 1 |
Hospira UK Ltd., Обединено Кралство |
Hospira UK, Ltd Queensway Royal Leamington Spa Warwiskshire CV313RW, Обединеното кралство;Hospira S.p.a Via Fosse Ardeatine 2, Liscate, Италия |
687 |
137.4 |
824.4 |
4% |
10 |
697 |
139.4 |
836.4 |
16% |
25 |
722 |
144.4 |
866.4 |
|
КЦРР-1177/08.08.2012 |
24.08.2012 |
24.08.2012 |
Неактивен |
1299 |
| Docetaxel |
20100475 |
DOCETAXEL HOSPIRA, Concentrate for solution for infusion, 10 mg/ml - 2 ml, mg, Pack: 1 |
Hospira UK Ltd., Обединено Кралство |
Hospira UK Ltd. QUEENSWAY, Великобритания, Hospira S.p.A, Италия |
86 |
17.2 |
103.2 |
4% |
3.44 |
89.44 |
17.89 |
107.33 |
16% |
13.76 |
103.2 |
20.64 |
123.84 |
|
НСР-1214/23.09.2013 |
11.10.2013 |
11.10.2013 |
Неактивен |
2924 |
| Docetaxel |
№ ІІ - 10282/16.07.2010 |
DOCETAXEL HOSPIRA, Concentrate for solution for infusion, 10 mg/ml - 2 ml, mg, Pack: 1 |
Hospira UK Ltd., Обединено Кралство |
Hospira UK Ltd. QUEENSWAY, Великобритания, Hospira S.p.A, Италия |
154.51 |
30.9 |
185.41 |
4% |
6.18 |
160.69 |
32.14 |
192.83 |
16% |
24.72 |
185.41 |
37.08 |
222.49 |
|
КЦ-2370-a/22.06.2011 |
07.07.2011 |
07.07.2011 |
Неактивен |
2924 |
| Docetaxel |
20100475 |
DOCETAXEL HOSPIRA, Concentrate for solution for infusion, 10 mg/ml - 8 ml, mg, Pack: 1 |
Hospira UK Ltd., Обединено Кралство |
Hospira UK Ltd. QUEENSWAY, Великобритания, Hospira S.p.A, Италия |
343.95 |
68.79 |
412.74 |
4% |
10 |
353.95 |
70.79 |
424.74 |
16% |
25 |
378.95 |
75.79 |
454.74 |
|
НСР-1214/23.09.2013 |
11.10.2013 |
11.10.2013 |
Неактивен |
2925 |
| Docetaxel |
№ ІІ - 10282/16.07.2010 |
DOCETAXEL HOSPIRA, Concentrate for solution for infusion, 10 mg/ml - 8 ml, mg, Pack: 1 |
Hospira UK Ltd., Обединено Кралство |
Hospira UK Ltd. QUEENSWAY, Великобритания, Hospira S.p.A, Италия |
616.09 |
123.22 |
739.31 |
4% |
10 |
626.09 |
125.22 |
751.31 |
16% |
25 |
651.09 |
130.22 |
781.31 |
|
КЦ-2369-a/22.06.2011 |
07.07.2011 |
07.07.2011 |
Неактивен |
2925 |
| Docetaxel |
EU/1/12/770/001 |
Docetaxel Kabi, Concentrate for solution for infusion, 80 mg/4 ml, mg, Pack: 1 |
Fresenius Kabi Oncology Plc., Обединено Кралство |
Fresenius Kabi Oncology Plc., Lion Court Farnham Road, Bordon, Hampschire GU35 0NF Обединено кралство |
86.06 |
17.21 |
103.27 |
4% |
3.44 |
89.5 |
17.9 |
107.4 |
16% |
13.77 |
103.27 |
20.65 |
123.92 |
|
НСР-7022/25.08.2015.; НСР-10939/17.11.2016; НСР-18078/01.03.2019 |
06.12.2016 |
02.04.2019 |
Заличен |
969 |
| Docetaxel |
EU/1/12/770/001 |
Docetaxel Kabi, Concentrate for solution for infusion, 80 mg/4 ml, mg, Pack: 1 |
Fresenius Kabi Oncology Plc., Обединено Кралство |
Fresenius Kabi Oncology Plc., Lion Court Farnham Road, Bordon, Hampschire GU35 0NF Обединено кралство |
86.06 |
17.21 |
103.27 |
4% |
3.44 |
89.5 |
17.9 |
107.4 |
16% |
13.77 |
103.27 |
20.65 |
123.92 |
|
НСР-7022/25.08.2015.; НСР-10939/17.11.2016 |
06.12.2016 |
02.01.2017 |
Неактивен |
969 |
| Docetaxel |
EU/1/12/770/001 |
Docetaxel Kabi, Concentrate for solution for infusion, 80 mg/4 ml, mg, Pack: 1 |
Fresenius Kabi Oncology Plc., Обединено Кралство |
Fresenius Kabi Oncology Plc., Lion Court Farnham Road, Bordon, Hampschire GU35 0NF Обединено кралство |
167.81 |
33.56 |
201.37 |
4% |
6.71 |
174.52 |
34.9 |
209.42 |
16% |
25 |
199.52 |
39.9 |
239.42 |
|
НСР-7022/25.08.2015. |
10.09.2015 |
10.09.2015 |
Неактивен |
969 |
| Docetaxel |
EU/1/12/770/001 |
Docetaxel Kabi, Concentrate for solution for infusion, 80 mg/4 ml, mg, Pack: 1 |
Fresenius Kabi Oncology Plc., Обединено Кралство |
Fresenius Kabi Oncology Plc., Lion Court Farnham Road, Bordon, Hampschire GU35 0NF Обединено кралство |
268.44 |
53.69 |
322.13 |
4% |
10 |
278.44 |
55.69 |
334.13 |
16% |
25 |
303.44 |
60.69 |
364.13 |
|
НСР-3539/16.05.2014 |
03.06.2014 |
03.06.2014 |
Неактивен |
969 |
| Docetaxel |
EU/1/12/770/001 |
Docetaxel Kabi, Concentrate for solution for infusion, 80 mg/4 ml, mg, Pack: 1 |
Fresenius Kabi Oncology Plc., Обединено Кралство |
Fresenius Kabi Oncology Plc., Lion Court Farnham Road, Bordon, Hampschire GU35 0NF Обединено кралство |
378.71 |
75.74 |
454.45 |
4% |
10 |
388.71 |
77.74 |
466.45 |
16% |
25 |
413.71 |
82.74 |
496.45 |
|
НСР-929/12.08.2013 |
02.09.2013 |
02.09.2013 |
Неактивен |
969 |
| Docetaxel |
EU/1/12/770/001 |
Docetaxel Kabi, Concentrate for solution for infusion, 80 mg/4 ml, mg, Pack: 1 |
Fresenius Kabi Oncology Plc., Обединено Кралство |
Fresenius Kabi Oncology Plc., Lion Court Farnham Road, Bordon, Hampschire GU35 0NF Обединено кралство |
406.97 |
81.39 |
488.36 |
4% |
10 |
416.97 |
83.39 |
500.36 |
16% |
25 |
441.97 |
88.39 |
530.36 |
|
КЦРР-1736/04.12.2012 г |
20.12.2012 |
20.12.2012 |
Неактивен |
969 |
| Docetaxel |
20190146 |
Docetaxel Novamed, Concentrate for solution for infusion, 20 mg/ml - 8 ml, -, Pack: 1 |
Новамед Трейдинг ЕООД, България |
Seacross Pharmaceuticals Limited, Обединено кралство |
129.08 |
25.82 |
154.9 |
4% |
5.16 |
134.24 |
26.85 |
161.09 |
16% |
20.65 |
154.89 |
30.98 |
185.87 |
|
НСР-19926/10.10.2019 |
25.10.2019 |
02.11.2019 |
Активен |
16740 |
| Docetaxel |
20190146 |
Docetaxel Novamed, Concentrate for solution for infusion, 20 mg/ml - 4 ml, -, Pack: 1 |
Новамед Трейдинг ЕООД, България |
Seacross Pharmaceuticals Limited, Обединено кралство |
64.54 |
12.91 |
77.45 |
4% |
2.58 |
67.12 |
13.42 |
80.54 |
16% |
10.33 |
77.45 |
15.49 |
92.94 |
|
НСР-19926/10.10.2019 |
25.10.2019 |
02.11.2019 |
Активен |
16741 |
| Morphine |
II-7053/04,03,2010 |
Doltard, Prolonged release tablet, 30, mg, Pack: 100 |
Takeda Pharma A/S, Дания |
Takeda Pharma A/S, Дания |
16.8 |
3.36 |
20.16 |
6% |
1.01 |
17.81 |
3.56 |
21.37 |
18% |
3.02 |
20.83 |
4.17 |
25 |
|
НСР-6145/29.04.2015. |
14.05.2015 |
14.05.2015 |
Активен |
3860 |
| Morphine |
II-7053/04,03,2010 |
Doltard, Prolonged release tablet, 30, mg, Pack: 100 |
Takeda Pharma A/S, Дания |
Takeda Pharma A/S, Дания |
37.86 |
7.57 |
45.43 |
4% |
1.51 |
39.37 |
7.87 |
47.24 |
16% |
6.06 |
45.43 |
9.09 |
54.52 |
промяна на обстоятелства НСР-2926/07.03.2014 |
КЦ-1447/09.03.2010 |
26.03.2010 |
26.03.2010 |
Неактивен |
3860 |
| Donepezil |
20080023 |
DONECEPT, Film coated tablet, 10, mg, Pack: 30 |
Актавис EАД, България |
Actavis Ltd., Malta |
9.02 |
1.8 |
10.82 |
7% |
0.63 |
9.65 |
1.93 |
11.58 |
20% |
1.8 |
11.45 |
2.29 |
13.74 |
|
НСР-3142/26.03.2014; НСР-11634/03.02.2017 |
10.04.2014 |
02.03.2017 |
Заличен |
2626 |
| Donepezil |
20080023 |
DONECEPT, Film coated tablet, 10, mg, Pack: 30 |
Актавис EАД, България |
Actavis Ltd., Malta |
9.02 |
1.8 |
10.82 |
7% |
0.63 |
9.65 |
1.93 |
11.58 |
20% |
1.8 |
11.45 |
2.29 |
13.74 |
|
НСР-3142/26.03.2014 |
10.04.2014 |
10.04.2014 |
Неактивен |
2626 |
| Donepezil |
20080022 |
DONECEPT, Film coated tablet, 5, mg, Pack: 30 |
Актавис EАД, България |
Actavis Ltd., Malta |
12.18 |
2.44 |
14.62 |
6% |
0.73 |
12.91 |
2.58 |
15.49 |
18% |
2.19 |
15.1 |
3.02 |
18.12 |
|
НСР-3141/26.03.2014; НСР-11454/13.01.2017 |
10.04.2014 |
02.02.2017 |
Заличен |
2625 |
| Donepezil |
20080022 |
DONECEPT, Film coated tablet, 5, mg, Pack: 30 |
Актавис EАД, България |
Actavis Ltd., Malta |
12.18 |
2.44 |
14.62 |
6% |
0.73 |
12.91 |
2.58 |
15.49 |
18% |
2.19 |
15.1 |
3.02 |
18.12 |
|
НСР-3141/26.03.2014 |
10.04.2014 |
10.04.2014 |
Неактивен |
2625 |
| Donepezil |
№ II-1560/ 11.02.2008 |
DONECEPT, Film coated tablet, 10, mg, Pack: 30 |
Актавис EАД, България |
Actavis Ltd., Malta |
9.56 |
1.91 |
11.47 |
7% |
0.67 |
10.23 |
2.05 |
12.28 |
20% |
1.91 |
12.14 |
2.43 |
14.57 |
|
HCР-356/03.07.2013. |
18.07.2013 |
18.07.2013 |
Неактивен |
2626 |
| Donepezil |
№ II-1559/ 11.02.2008 |
DONECEPT, Film coated tablet, 5, mg, Pack: 30 |
Актавис EАД, България |
Actavis Ltd., Malta |
12.95 |
2.59 |
15.54 |
6% |
0.78 |
13.73 |
2.75 |
16.48 |
18% |
2.33 |
16.06 |
3.21 |
19.27 |
|
HCР-358/03.07.2013. |
18.07.2013 |
18.07.2013 |
Неактивен |
2625 |
| Donepezil |
№ II-1560/ 11.02.2008 |
DONECEPT, Film coated tablet, 10, mg, Pack: 30 |
Актавис EАД, България |
Actavis Ltd., Malta |
44.83 |
8.97 |
53.8 |
4% |
1.79 |
46.62 |
9.32 |
55.94 |
16% |
7.17 |
53.79 |
10.76 |
64.55 |
|
КЦРР-503/19.04.2012 |
06.05.2012 |
06.05.2012 |
Неактивен |
2626 |
| Donepezil |
№ II-1559/ 11.02.2008 |
DONECEPT, Film coated tablet, 5, mg, Pack: 30 |
Актавис EАД, България |
Actavis Ltd., Malta |
38.96 |
7.79 |
46.75 |
4% |
1.56 |
40.52 |
8.1 |
48.62 |
16% |
6.23 |
46.75 |
9.35 |
56.1 |
|
КЦРР-503/19.04.2012 |
06.05.2012 |
06.05.2012 |
Неактивен |
2625 |